(Q57173889)

English

The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine

scientific article published in 2007

In more languages

Statements

scholarly article

0 references

The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

2

object named as

Ray Borrow

0 references

author name string

Paul Balmer

1

0 references

Peter D. Arkwright

3

0 references

language of work or name

0 references

publication date

August 2007

0 references

0 references

25

0 references

34

0 references

6321-6325

0 references

Estimates of world-wide distribution of child deaths from acute respiratory infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Pneumococcal vaccines: an update on current strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.021

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.06.021

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57173889&oldid=2209334352"